<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK47027" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK47027/" /><meta name="ncbi_pagename" content="Perry Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Perry Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Perry Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/09/29" /><meta name="citation_author" content="Zbigniew Wszolek" /><meta name="citation_author" content="Takuya Konno" /><meta name="citation_pmid" content="20945553" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK47027/" /><meta name="citation_keywords" content="Dynactin subunit 1" /><meta name="citation_keywords" content="DCTN1" /><meta name="citation_keywords" content="Perry Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Perry Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Zbigniew Wszolek" /><meta name="DC.Contributor" content="Takuya Konno" /><meta name="DC.Date" content="2016/09/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK47027/" /><meta name="description" content="Perry syndrome is characterized by parkinsonism, hypoventilation, depression, and weight loss. The mean age at onset is 49 years; the mean disease duration is five years. Parkinsonism and psychiatric changes (depression, apathy, character changes, and withdrawal) tend to occur early; severe weight loss and hypoventilation manifest later." /><meta name="og:title" content="Perry Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Perry syndrome is characterized by parkinsonism, hypoventilation, depression, and weight loss. The mean age at onset is 49 years; the mean disease duration is five years. Parkinsonism and psychiatric changes (depression, apathy, character changes, and withdrawal) tend to occur early; severe weight loss and hypoventilation manifest later." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK47027/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/perry/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK47027/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B4622E03F98E100000000099E037A.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK47027_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK47027_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/perrault/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/peters-plus/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK47027_"><span class="title" itemprop="name">Perry Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Zbigniew Wszolek</span>, MD and <span itemprop="author">Takuya Konno</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK47027_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK47027_ai__"><div class="contrib half_rhythm"><span itemprop="author">Zbigniew Wszolek</span>, MD<div class="affiliation small">Department of Neurology<br />Mayo Clinic<br />Jacksonville, Florida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@weingibz.kelozsw" class="oemail">ude.oyam@weingibz.kelozsw</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Takuya Konno</span>, MD<div class="affiliation small">Department of Neurology<br />Mayo Clinic<br />Jacksonville, Florida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@ayukat.onnok" class="oemail">ude.oyam@ayukat.onnok</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 30, 2010</span>; Last Update: <span itemprop="dateModified">September 29, 2016</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="perry.Summary" itemprop="description"><h2 id="_perry_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Perry syndrome is characterized by parkinsonism, hypoventilation, depression, and weight loss. The mean age at onset is 49 years; the mean disease duration is five years. Parkinsonism and psychiatric changes (depression, apathy, character changes, and withdrawal) tend to occur early; severe weight loss and hypoventilation manifest later.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Perry syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with all four of the cardinal features:</p><ul><li class="half_rhythm"><div>Early-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> parkinsonism</div></li><li class="half_rhythm"><div>Mood/personality changes</div></li><li class="half_rhythm"><div>Weight loss</div></li><li class="half_rhythm"><div>Central hypoventilation</div></li></ul><p>Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> confirms the diagnosis if clinical features are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Dopaminergic therapy (particularly carbidopa/levodopa) should be considered in all individuals with significant parkinsonism. Although response to levodopa is often poor, some individuals may have long-term benefit. At times large doses of carbidopa/levodopa are required. Ventilation support may prolong life expectancy and improve quality of life. Those individuals with psychiatric manifestations may benefit from antidepressants and psychiatric care. Weight loss is managed with appropriate dietary changes.</p><p><i>Prevention of secondary complications:</i> Adequate caloric intake to prevent weight loss.</p><p><i>Surveillance:</i> Routine evaluation of weight and calorie intake, respiratory function (particularly at night or during sleep), motor function, and mood/personality changes.</p><p><i>Agents/circumstances to avoid:</i> Central respiratory depressants (e.g., benzodiazepines, alcohol, narcotics).</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Perry syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The proportion of cases attributed to a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown. Each child of an individual with Perry syndrome has a 50% chance of inheriting the pathogenic variant. Prenatal testing is possible for families in which the pathogenic variant has been identified.</p></div></div><div id="perry.Diagnosis"><h2 id="_perry_Diagnosis_">Diagnosis</h2><div id="perry.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Perry syndrome <b>should be suspected</b> in individuals with these cardinal clinical features:</p><ul><li class="half_rhythm"><div>Early-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> parkinsonism</div></li><li class="half_rhythm"><div>Mood/personality changes (depression, apathy, withdrawal, disinhibition)</div></li><li class="half_rhythm"><div>Weight loss</div></li><li class="half_rhythm"><div>Central hypoventilation</div></li></ul><p>Diagnostic criteria were previously proposed prior to the availability of molecular and immunohistochemistry testing [<a class="bk_pop" href="#perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</a>]. However, with the availability of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> they are no longer crucial for the diagnosis.</p></div><div id="perry.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Perry syndrome <b>can be established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has ALL of the above cardinal features.</p><p>Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> confirms the diagnosis if clinical features are inconclusive (see <a class="figpopup" href="/books/NBK47027/table/perry.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figperryTmoleculargenetictestingusedi" rid-ob="figobperryTmoleculargenetictestingusedi">Table 1</a>). Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>DCTN1.</i></div><div class="half_rhythm">Note: Since Perry syndrome occurs through a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> mechanism (see <a href="#perry.Molecular_Genetics">Molecular Genetics</a>) and large intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> has not been reported, testing for intragenic deletions or duplication is unlikely to identify a disease-causing variant. Detailed genetic studies for intragenic deletions or duplications have not been conducted.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>DCTN1</i> and other genes of interest (see <a href="#perry.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>DCTN1</i>) fails to confirm a diagnosis in an individual with features of Perry syndrome. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="perry.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Perry syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47027/table/perry.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__perry.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>DCTN1</i></td><td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21/21 (100%)&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_perry.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="perry.TF.1.1"><p class="no_margin">See <a href="/books/NBK47027/#perry.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="perry.TF.1.2"><p class="no_margin">See <a href="#perry.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="perry.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="perry.TF.1.4"><p class="no_margin">All 21 probands with Perry syndrome reported thus far have one of nine <i>DCTN1</i> pathogenic variants located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 (see <a class="figpopup" href="/books/NBK47027/table/perry.T.dctn1_selected_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figperryTdctn1selectedpathogenicvarian" rid-ob="figobperryTdctn1selectedpathogenicvarian">Table 2</a>) [<a class="bk_pop" href="#perry.REF.farrer.2009.163">Farrer et al 2009</a>, <a class="bk_pop" href="#perry.REF.newsway.2010.767">Newsway et al 2010</a>, <a class="bk_pop" href="#perry.REF.ohshima.2010.612">Ohshima et al 2010</a>, <a class="bk_pop" href="#perry.REF.wider.2010.149">Wider et al 2010</a>, <a class="bk_pop" href="#perry.REF.aji.2013.117">Aji et al 2013</a>, <a class="bk_pop" href="#perry.REF.araki.2014.1201">Araki et al 2014</a>, <a class="bk_pop" href="#perry.REF.caroppo.2014.208">Caroppo et al 2014</a>, <a class="bk_pop" href="#perry.REF.chung.2014.388">Chung et al 2014</a>, <a class="bk_pop" href="#perry.REF.pretelt.2014.620">Pretelt et al 2014</a>, <a class="bk_pop" href="#perry.REF.tacik.2014.884">Tacik et al 2014</a>, <a class="bk_pop" href="#perry.REF.barreto.2015.s304">Barreto et al 2015</a>, <a class="bk_pop" href="#perry.REF.gustavsson.2016.56">Gustavsson et al 2016</a>].</p></div></dd><dt>5. </dt><dd><div id="perry.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="perry.TF.1.6"><p class="no_margin">Since Perry syndrome occurs through a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> mechanism and large intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> has not been reported, testing for intragenic deletions or duplication is unlikely to identify a disease-causing variant.</p></div></dd></dl></div></div></div></div></div><div id="perry.Clinical_Characteristics"><h2 id="_perry_Clinical_Characteristics_">Clinical Characteristics</h2><div id="perry.Clinical_Description"><h3>Clinical Description</h3><p>The cardinal findings of Perry syndrome are parkinsonism, hypoventilation, depression, and weight loss [<a class="bk_pop" href="#perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</a>, <a class="bk_pop" href="#perry.REF.wider.2010.149">Wider et al 2010</a>]. The mean age at onset is 49 years (range: 35-70 years) and the mean disease duration is five years (range: 2-14 years). Psychiatric (depression, apathy, character changes, withdrawal) and motor (parkinsonism) symptoms tend to occur early, whereas severe weight loss and hypoventilation manifest later. In most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons the reported cause/circumstance of death relates to sudden death/hypoventilation or suicide [<a class="bk_pop" href="#perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</a>].</p><p><b>Parkinsonism.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals present with akinetic-rigid and rather symmetric parkinsonism that is less severe than that found in Parkinson disease. When present, tremor is often postural; however, typical rest tremor has been reported.</p><p><b>Hypoventilation.</b> Alveolar hypoventilation manifests particularly at night or during sleep with tachypnea alternating with normal respiratory cycles, leading to frequent awakenings. Polysomnographic recordings show that hypoxemia and hypercapnia are of central origin; that is, there is no obstructive or structural respiratory tract abnormality. One detailed autopsy study demonstrated significant neuronal loss in regions critical for respiratory drive (ventrolateral medulla [pre-B&#x000f6;tzinger complex] and dorsal raphe nucleus), which may account for central hypoventilation [<a class="bk_pop" href="#perry.REF.tsuboi.2008.263">Tsuboi et al 2008</a>]. Of note, hypoventilation was not reported in one of the ten families with molecularly confirmed Perry syndrome [<a class="bk_pop" href="#perry.REF.roy.1988.637">Roy et al 1988</a>, <a class="bk_pop" href="#perry.REF.farrer.2009.163">Farrer et al 2009</a>].</p><p>Sleep difficulties, a common complaint, reflect hypoventilation.</p><p><b>Depression.</b> Psychiatric findings are dominated by apathy, social withdrawal, and "loss of psychic self-activation" (referred to as "athymhormia" in the French literature), although true depression has also been reported.</p><p>One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual also presented with frontotemporal dementia-type behavioral manifestations, downward gaze abnormalities, and autonomic dysfunction [<a class="bk_pop" href="#perry.REF.newsway.2010.767">Newsway et al 2010</a>].</p><p><b>Weight loss.</b> No anatomic substrate has been reported to account for severe weight loss. Additionally, in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals weight loss cannot be attributed to significant dysphagia. Weight loss may in fact reflect psychiatric changes; however, mechanisms involving central modification of hunger sensation or an increase in metabolic rate cannot be excluded.</p><p><b>Autonomic failure.</b> In one family from Japan with a <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals displayed early and severe autonomic failure [<a class="bk_pop" href="#perry.REF.ohshima.2010.612">Ohshima et al 2010</a>].</p><p><b>Neuroimaging</b></p><ul><li class="half_rhythm"><div>Structural brain imaging is usually normal.</div></li><li class="half_rhythm"><div>Functional imaging using 18-fluorodeoxyglucose PET (FDG-PET) showed reduced metabolic rate in the lateral prefrontal and temporal regions in one study [<a class="bk_pop" href="#perry.REF.lechevalier.2005.481">Lechevalier et al 2005</a>].</div></li><li class="half_rhythm"><div>Dopaminergic pathway functional imaging using 18-fluorodopa PET (FD-PET) showed reduced striatal tracer uptake [<a class="bk_pop" href="#perry.REF.perry.1990.1882">Perry et al 1990</a>, <a class="bk_pop" href="#perry.REF.felicio.2014.1197">Felicio et al 2014</a>]. The tracer reduction uptake was also observed to a lesser extent in an individual with a <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who did not have clinical features of Perry syndrome [<a class="bk_pop" href="#perry.REF.felicio.2014.1197">Felicio et al 2014</a>].</div></li><li class="half_rhythm"><div>Serotonin transporter imaging using <sup>11</sup>C-3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB-PET) showed reduced tracer uptake in cortical and subcortical regions [<a class="bk_pop" href="#perry.REF.felicio.2014.1197">Felicio et al 2014</a>].</div></li><li class="half_rhythm"><div>Transcranial sonography showed hyperechogenicity in the substantia nigra comparable to that observed in Parkinson disease [<a class="bk_pop" href="#perry.REF.saka.2010.68">Saka et al 2010</a>].</div></li><li class="half_rhythm"><div>In four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in one family from Japan, decreased cardiac uptake with [123]-metaiodobenzylguanidine scintigram was reported [<a class="bk_pop" href="#perry.REF.ohshima.2010.612">Ohshima et al 2010</a>].</div></li></ul><p><b>Neuropathology.</b> Histology shows severe neuronal loss in the substantia nigra, with no Lewy bodies. Lesser degrees of neuronal loss are found in the <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> ceruleus, lentiform nucleus, hypothalamus, periaqueductal gray matter, dorsal raphe nucleus, and brain stem reticular formation [<a class="bk_pop" href="#perry.REF.wider.2009.281">Wider et al 2009</a>]. Specific loss of putative respiratory neurons was demonstrated in the ventrolateral medulla and dorsal raphe nucleus [<a class="bk_pop" href="#perry.REF.tsuboi.2008.263">Tsuboi et al 2008</a>].</p><p>Immunohistochemistry shows ubiquitin- and transactive response DNA-binding protein 43 (TDP-43)-positive neuronal inclusions, dystrophic neurites, glial cytoplasmic inclusions, and axonal spheroids [<a class="bk_pop" href="#perry.REF.wider.2009.281">Wider et al 2009</a>]. TDP-43-positive inclusions predominate in regions belonging to the extrapyramidal system including the substantia nigra, globus pallidus, striatum, and subthalamic nucleus. Interestingly, TDP-43-positive inclusions in persons with Perry syndrome resemble those found in ubiquitin-positive frontotemporal lobar degeneration (FTLD-U) and <a href="/books/n/gene/als-overview/">amyotrophic lateral sclerosis</a> (ALS), although with distinct regional distributions.</p></div><div id="perry.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Eight pathogenic variants in <i>DCTN1</i> have been associated with Perry syndrome (see <a class="figpopup" href="/books/NBK47027/table/perry.T.dctn1_selected_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figperryTdctn1selectedpathogenicvarian" rid-ob="figobperryTdctn1selectedpathogenicvarian">Table 2</a>) [<a class="bk_pop" href="#perry.REF.farrer.2009.163">Farrer et al 2009</a>, <a class="bk_pop" href="#perry.REF.aji.2013.117">Aji et al 2013</a>, <a class="bk_pop" href="#perry.REF.araki.2014.1201">Araki et al 2014</a>, <a class="bk_pop" href="#perry.REF.chung.2014.388">Chung et al 2014</a>, <a class="bk_pop" href="#perry.REF.tacik.2014.884">Tacik et al 2014</a>]. No clear <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation exists, in that families/individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>DCTN1</i> do not necessarily share the same phenotype.</p><p>Persons with Perry syndrome may not develop all of the cardinal manifestations. For example, individuals from the same family may not have hypoventilation and weight loss, and others may lack psychiatric symptoms [<a class="bk_pop" href="#perry.REF.wider.2010.149">Wider et al 2010</a>].</p></div><div id="perry.Penetrance"><h3>Penetrance</h3><p>Although precise estimates have not been calculated given the limited number of families reported, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is age related and high, with all asymptomatic heterozygotes being younger than or within the range of onset age.</p></div><div id="perry.Nomenclature"><h3>Nomenclature</h3><p>Before Perry syndrome became the prevailing term for the disorder, several terms had been used to describe this condition, including hereditary mental depression and parkinsonism with taurine deficiency [<a class="bk_pop" href="#perry.REF.perry.1975.108">Perry et al 1975</a>], <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> fatal parkinsonism with alveolar hypoventilation and mental depression [<a class="bk_pop" href="#perry.REF.purdy.1979.523">Purdy et al 1979</a>], familial parkinsonism, apathy, weight loss, and central hypoventilation [<a class="bk_pop" href="#perry.REF.roy.1988.637">Roy et al 1988</a>], dominantly inherited apathy, central hypoventilation, and Parkinson&#x02019;s syndrome [<a class="bk_pop" href="#perry.REF.perry.1990.1882">Perry et al 1990</a>], familial parkinsonism with athymhormia and hypoventilation [<a class="bk_pop" href="#perry.REF.lechevalier.1992.39">Lechevalier et al 1992</a>], familial parkinsonism with depression [<a class="bk_pop" href="#perry.REF.bhatia.1993.842">Bhatia et al 1993</a>], and familial parkinsonism with apathy, depression, and central hypoventilation [<a class="bk_pop" href="#perry.REF.elibol.2002">Elibol et al 2002</a>].</p><p>"Perry syndrome" has appeared in the literature since 2002 [<a class="bk_pop" href="#perry.REF.elibol.2002">Elibol et al 2002</a>]; it is named after Professor Thomas L Perry, who reported the first Canadian family with this disease.</p></div><div id="perry.Prevalence"><h3>Prevalence</h3><p>Since the original reports of <a class="bk_pop" href="#perry.REF.perry.1975.108">Perry et al [1975]</a> and <a class="bk_pop" href="#perry.REF.perry.1990.1882">Perry et al [1990]</a>, 21 additional families have been reported from Canada, the United States, the United Kingdom, Japan, France, Turkey, New Zealand, Colombia, Korea, Portugal, and Taiwan [<a class="bk_pop" href="#perry.REF.purdy.1979.523">Purdy et al 1979</a>, <a class="bk_pop" href="#perry.REF.roy.1988.637">Roy et al 1988</a>, <a class="bk_pop" href="#perry.REF.lechevalier.1992.39">Lechevalier et al 1992</a>, <a class="bk_pop" href="#perry.REF.tsuboi.2002.1025">Tsuboi et al 2002</a>, <a class="bk_pop" href="#perry.REF.lechevalier.2005.481">Lechevalier et al 2005</a>, <a class="bk_pop" href="#perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</a>, <a class="bk_pop" href="#perry.REF.newsway.2010.767">Newsway et al 2010</a>, <a class="bk_pop" href="#perry.REF.ohshima.2010.612">Ohshima et al 2010</a>, <a class="bk_pop" href="#perry.REF.saka.2010.68">Saka et al 2010</a>, <a class="bk_pop" href="#perry.REF.wider.2010.149">Wider et al 2010</a>, <a class="bk_pop" href="#perry.REF.aji.2013.117">Aji et al 2013</a>, <a class="bk_pop" href="#perry.REF.chung.2014.388">Chung et al 2014</a>, <a class="bk_pop" href="#perry.REF.pretelt.2014.620">Pretelt et al 2014</a>, <a class="bk_pop" href="#perry.REF.tacik.2014.884">Tacik et al 2014</a>, <a class="bk_pop" href="#perry.REF.araki.2014.1201">Araki et al 2014</a>, <a class="bk_pop" href="#perry.REF.caroppo.2014.208">Caroppo et al 2014</a>, <a class="bk_pop" href="#perry.REF.barreto.2015.s304">Barreto et al 2015</a>, <a class="bk_pop" href="#perry.REF.gustavsson.2016.56">Gustavsson et al 2016</a>].</p></div></div><div id="perry.Genetically_Related_Allelic_Disord"><h2 id="_perry_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>Distal hereditary motor neuropathy type VIIB (HMN7B) was associated with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> p.Gly59Ser <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in one family [<a class="bk_pop" href="#perry.REF.puls.2003.455">Puls et al 2003</a>, <a class="bk_pop" href="#perry.REF.puls.2005.687">Puls et al 2005</a>]<i>.</i> Another variant, p.Glu340Gly, has been identified in an individual with inherited peripheral neuropathy; the pathogenicity of this variant remains unclear [<a class="bk_pop" href="#perry.REF.nam.2016.382">Nam et al 2016</a>]. No clinical or pathologic overlap was observed between HMN7B and Perry syndrome [<a class="bk_pop" href="#perry.REF.wider.2010.149">Wider et al 2010</a>]. In HMN7B, the mean age at onset is 34 years (range: 23-44 years); affected individuals present with a lower motor neuron syndrome involving mainly the larynx, face, and upper limbs [<a class="bk_pop" href="#perry.REF.puls.2005.687">Puls et al 2005</a>]. In contrast with Perry syndrome, in which death occurs within ten years, progression in HMN7B is very slow (&#x0003e;30 years in some individuals). Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants have also been identified in several individuals and families with progressive supranuclear palsy (PSP)-like symptoms, including supranuclear gaze palsy, frequent falls, and eyelid apraxia [<a class="bk_pop" href="#perry.REF.newsway.2010.767">Newsway et al 2010</a>, <a class="bk_pop" href="#perry.REF.aji.2013.117">Aji et al 2013</a>, <a class="bk_pop" href="#perry.REF.araki.2014.1201">Araki et al 2014</a>, <a class="bk_pop" href="#perry.REF.caroppo.2014.208">Caroppo et al 2014</a>, <a class="bk_pop" href="#perry.REF.chung.2014.388">Chung et al 2014</a>, <a class="bk_pop" href="#perry.REF.barreto.2015.s304">Barreto et al 2015</a>, <a class="bk_pop" href="#perry.REF.gustavsson.2016.56">Gustavsson et al 2016</a>]. None of the individuals had pathologically confirmed PSP.</p><p>Pathogenic variants in <i>DCTN1</i> appear to be rare in individuals with other neurodegenerative diseases. Several <i>DCTN1</i> variants have been identified in individuals with amyotrophic lateral sclerosis (ALS), but none of the variants were considered definite pathogenic variants for various reasons including incomplete <a class="def" href="/books/n/gene/glossary/def-item/segregation/">segregation</a>, a lack of functional analysis, and the fact that some variants were identified in individuals without ALS [<a class="bk_pop" href="#perry.REF.m_nch.2004.724">M&#x000fc;nch et al 2004</a>, <a class="bk_pop" href="#perry.REF.m_nch.2005.777">M&#x000fc;nch et al 2005</a>, <a class="bk_pop" href="#perry.REF.takahashi.2008.1326">Takahashi et al 2008</a>, <a class="bk_pop" href="#perry.REF.vilari_og_ell.2009.2024">Vilari&#x000f1;o-G&#x000fc;ell et al 2009</a>, <a class="bk_pop" href="#perry.REF.stockmann.2013.785">Stockmann et al 2013</a>, <a class="bk_pop" href="#perry.REF.liu.2014.2881.e11">Liu et al 2014</a>, <a class="bk_pop" href="#perry.REF.cady.2015.100">Cady et al 2015</a>].</p></div><div id="perry.Differential_Diagnosis"><h2 id="_perry_Differential_Diagnosis_">Differential Diagnosis</h2><p>Other forms of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> early-onset parkinsonism that need to be distinguished from Perry syndrome include those types caused by mutation of <i>PRKN</i> (<i>PARK2</i>) (see <a href="/books/n/gene/jpd/">Parkin Type of Early-Onset Parkinson Disease</a>), <i>PINK1</i> (see <a href="/books/n/gene/pink1-pd/"><i>PINK1</i> Type of Young-Onset Parkinson Disease</a>), <i>PARK7</i> (formerly <i>DJ-1</i>), or <i>LRRK2</i> (see <a href="/books/n/gene/lrrk2/"><i>LRRK2</i>-Related Parkinson Disease</a>). The findings of personality changes, weight loss, and hypoventilation in Perry syndrome tend to distinguish it from other forms of early-onset Parkinson disease (see <a href="/books/n/gene/parkinson-overview/">Parkinson Disease Overview</a>). Additionally, response to standard doses of levodopa is usually poorer or of shorter duration in Perry syndrome than in other forms of early-onset Parkinson disease.</p><p>Mood/personality changes in Perry syndrome may suggest frontotemporal dementia, which has a similar age of onset and is often associated with levodopa-resistant parkinsonism.</p><p>Perry syndrome needs to be distinguished from frontotemporal dementia caused by mutation of <i>MAPT</i> or <i>GRN</i> (see <a href="/books/n/gene/ftd-grn/"><i>GRN</i>-Related Frontotemporal Dementia</a>). An individual of Japanese ancestry who showed symptoms reminiscent of Perry syndrome was found to have an <i>MAPT</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. On autopsy examination, the brain showed tau-positive inclusions; transactive response DNA-binding protein 43 (TDP-43)-positive inclusions were not present [<a class="bk_pop" href="#perry.REF.omoto.2012.762">Omoto et al 2012</a>].</p></div><div id="perry.Management"><h2 id="_perry_Management_">Management</h2><div id="perry.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Perry syndrome the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic evaluation of motor function</div></li><li class="half_rhythm"><div>Sleep study and evaluation by a pulmonologist or sleep disorders consultant for ventilation support if required</div></li><li class="half_rhythm"><div>Psychiatric evaluation and (if needed) neuropsychological examination</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="perry.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Parkinsonism.</b> Dopaminergic therapy (particularly carbidopa/levodopa) should be considered in all individuals with significant parkinsonism. Response to levodopa is usually absent, erratic, or transient in Perry syndrome [<a class="bk_pop" href="#perry.REF.tsuboi.2002.1025">Tsuboi et al 2002</a>, <a class="bk_pop" href="#perry.REF.wider.2008.1">Wider &#x00026; Wszolek 2008</a>]. However, large doses of carbidopa/levodopa (&#x0003e;2g) have been used successfully to reduce rigidity, tremor, and other symptoms in two individuals, one from the new British kindred [<a class="bk_pop" href="#perry.REF.newsway.2010.767">Newsway et al 2010</a>] and one from the original Canadian family [J Stoessl, personal communication].</p><p><b>Hypoventilation.</b> Ventilation support (invasive or noninvasive) may prolong life expectancy and have a significant impact on quality of life. Several persons without evidence of daytime central hypoventilation or respiratory troubles died suddenly at night most likely as a result of nocturnal hypoventilation. Therefore, ventilation support may be needed only during sleep [Wider &#x00026; Wszolek, personal observation]. A bilateral diaphragmatic pacemaker may help combat respiratory insufficiency [<a class="bk_pop" href="#perry.REF.pretelt.2014.620">Pretelt et al 2014</a>].</p><p><b>Depression.</b> Psychiatric manifestations may require antidepressants and psychiatric follow up to help reduce risk of suicide.</p><p><b>Weight loss.</b> Careful weight follow up is indicated and high caloric intake should be considered if weight loss is present.</p></div><div id="perry.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Adequate caloric intake must be ensured to prevent weight loss.</p></div><div id="perry.Surveillance"><h3>Surveillance</h3><p>Routine evaluation of weight and calorie intake, respiratory function (particularly at night or during sleep), motor function, and mood/personality changes is appropriate.</p></div><div id="perry.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Use of central respiratory depressants (e.g., benzodiazepines, alcohol, narcotics) should be minimized.</p></div><div id="perry.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#perry.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="perry.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="perry.Genetic_Counseling"><h2 id="_perry_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="perry.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Perry syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="perry.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals diagnosed with Perry syndrome usually have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Perry syndrome may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Because <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if the pathogenic variant was <i>de novo</i>, the proportion of Perry syndrome caused by a <i>de novo</i> pathogenic variant is unknown.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include clinical and genetic evaluations. Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li><li class="half_rhythm"><div>Note: Although most individuals diagnosed with Perry syndrome have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for Perry syndrome because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low, but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with Perry syndrome has a 50% chance of inheriting the <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="perry.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Testing of at-risk asymptomatic adult relatives</b> of individuals with Perry syndrome is possible after <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has identified the specific <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. Such testing should be performed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p><p><b>Testing of asymptomatic individuals younger than age 18 years</b> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p><p>It is appropriate to consider testing symptomatic individuals regardless of age in a family with an established diagnosis of Perry syndrome.</p><p>For more information, see also the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/pediatrics/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="perry.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>DCTN1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for Perry syndrome are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="perry.Resources"><h2 id="_perry_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Parkinson Disease Association (APDA)</b></div><div>135 Parkinson Avenue</div><div>Staten Island NY 10305</div><div><b>Phone:</b> 800-223-2732 (toll-free); 718-981-8001</div><div><b>Fax:</b> 718-981-4399</div><div><b>Email:</b> apda@apdaparkinson.org</div><div><a href="http://www.apdaparkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apdaparkinson.org</a></div></li><li class="half_rhythm"><div><b>Michael J. Fox Foundation for Parkinson's Research</b></div><div>Church Street Station</div><div>PO Box 780</div><div>New York NY 10008-0780</div><div><b>Phone:</b> 800-708-7644 (toll-free)</div><div><b>Email:</b> info@michaeljfox.org</div><div><a href="http://www.michaeljfox.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.michaeljfox.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=parkinsondisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson disease</a></div></li><li class="half_rhythm"><div><b>Parkinson's Foundation</b></div><div>200 SE 1st Street</div><div>Suite 800</div><div>Miami FL 33131</div><div><b>Phone:</b> 800-4PD-INFO (473-4636)</div><div><b>Email:</b> contact@parkinson.org</div><div><a href="http://www.parkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.parkinson.org</a></div></li></ul></div><div id="perry.Molecular_Genetics"><h2 id="_perry_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="perry.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Perry Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47027/table/perry.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__perry.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_perry.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_perry.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_perry.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_perry.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_perry.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_perry.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_perry.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1639" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DCTN1</i></a></td><td headers="hd_b_perry.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1639" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_perry.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14203" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dynactin subunit 1</a></td><td headers="hd_b_perry.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://alsod.iop.kcl.ac.uk/Als/Overview/gene.aspx?gene_id=DCTN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">alsod/DCTN1 genetic mutations</a><br /><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=25" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, DCTN1</a><br /><a href="http://databases.lovd.nl/shared/genes/DCTN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DCTN1 homepage - Leiden Muscular Dystrophy pages</a><br /><a href="https://gwas.biosciencedbc.jp/cgi-bin/hvdb/hv_pos.cgi?gid=EG1639&#x00026;gchk=0&#x00026;vchk=0&#x00026;pchk=0&#x00026;nchk=0&#x00026;cchk=0&#x00026;lchk=0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALS mutation database (DCTN1)</a></td><td headers="hd_b_perry.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DCTN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DCTN1</a></td><td headers="hd_b_perry.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DCTN1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DCTN1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="perry.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="perry.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Perry Syndrome (<a href="/omim/168605,601143" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47027/table/perry.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__perry.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/168605" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">168605</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PERRY SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601143" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601143</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DYNACTIN 1; DCTN1</td></tr></tbody></table></div></div><div id="perry.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p><i>DCTN1</i> encodes p150<sup>(glued)</sup>, the major subunit of the dynactin protein complex [<a class="bk_pop" href="#perry.REF.farrer.2009.163">Farrer et al 2009</a>]. The dynactin protein complex plays a major role in retrograde axonal and cytoplasmic transport of vesicles, organelles, and other cargos through binding to its complex structure. p150(glued) contains the cytoskeleton-associated protein glycine-rich (CAP-Gly) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that is essential for microtubule binding. All <i>DCTN1</i> variants found in individuals with Perry syndrome are located in this domain. In vitro, <i>DCTN1</i> variants alter the ability of dynactin to bind microtubules, thereby impairing its function as a transport protein [<a class="bk_pop" href="#perry.REF.puls.2003.455">Puls et al 2003</a>, <a class="bk_pop" href="#perry.REF.levy.2006.733">Levy et al 2006</a>, <a class="bk_pop" href="#perry.REF.farrer.2009.163">Farrer et al 2009</a>, <a class="bk_pop" href="#perry.REF.lloyd.2012.344">Lloyd et al 2012</a>, <a class="bk_pop" href="#perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</a>].</p><p>The link between <i>DCTN1</i> pathogenic variants and neuronal dysfunction/death remains to be elucidated. For example, the fact that pathogenic variants causing Perry syndrome and HMN7B are located close to each other yet cause completely different clinical features with distinct distribution of affected neuronal systems constitutes a challenging puzzle [<a class="bk_pop" href="#perry.REF.wider.2010.149">Wider et al 2010</a>].</p><p><b>Gene structure.</b> Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> results in multiple transcript variants encoding distinct <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>. The reference sequence <a href="/nuccore/NM_004082.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004082.3</a> is known as isoform 1; details of other isoforms are available at <a href="/gene/1639" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Entrez Gene</a>.</p><p><b>Pathogenic variants.</b> All reported Perry syndrome-associated pathogenic variants in <i>DCTN1</i> are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. These variants induce a loss of CAP-Gly function. The p.Gly71Arg variant has a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect on initiation of retrograde transport [<a class="bk_pop" href="#perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</a>].</p><div id="perry.T.dctn1_selected_pathogenic_varian" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>DCTN1</i> Selected Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47027/table/perry.T.dctn1_selected_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__perry.T.dctn1_selected_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.156T&#x0003e;G</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe52Leu</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_3" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_004082.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004082<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_004073.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004073<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.167A&#x0003e;G</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys56Arg&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.175G&#x0003e;A</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly59Ser&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.200G&#x0003e;A</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly67Asp</td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.211G&#x0003e;A</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly71Arg</td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.212G&#x0003e;A</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly71Glu</td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.212G&#x0003e;C</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly71Ala</td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.214A&#x0003e;C</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr72Pro</td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.221A&#x0003e;C</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln74Pro</td></tr><tr><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.233A&#x0003e;G</td><td headers="hd_h_perry.T.dctn1_selected_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr78Cys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="perry.TF.2.1"><p class="no_margin">This <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in individuals with clinical PSP (no autopsy confirmation).</p></div></dd><dt>2. </dt><dd><div id="perry.TF.2.2"><p class="no_margin">This <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> causes HMN7B.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>DCTN1</i> encodes p150<sup>(glued)</sup>, the major subunit of the dynactin protein complex, which plays an important role in axonal and cytoplasmic transport.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>DCTN1</i> harboring single-nucleotide variants that cause Perry syndrome and HMN7B encodes abnormal forms of p150<sup>(glued)</sup>, which alter the affinity of dynactin for microtubules. Pathogenic variants associated with Perry syndrome are exposed to the surface of the CAP-Gly <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of p150<sup>(glued)</sup> [<a class="bk_pop" href="#perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</a>]. This abnormal p150<sup>(glued)</sup> fails to accumulate dynactin at the neurite tip, resulting in disruption of retrograde flux [<a class="bk_pop" href="#perry.REF.moughamian.2012.331">Moughamian &#x00026; Holzbaur 2012</a>].</p></div></div><div id="perry.References"><h2 id="_perry_References_">References</h2><div id="perry.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="perry.REF.aji.2013.117">Aji BM, Medley G, O'Driscoll K, Larner AJ, Alusi SH. Perry syndrome: a disorder to consider in the differential diagnosis of Parkinsonism. <span><span class="ref-journal">J Neurol Sci. </span>2013;<span class="ref-vol">330</span>:117–8.</span> [<a href="/pubmed/23628468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23628468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.araki.2014.1201">Araki E, Tsuboi Y, Daechsel J, Milnerwood A, Vilarino-Guell C, Fujii N, Mishima T, Oka T, Hara H, Fukae J, Farrer MJ. A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy. <span><span class="ref-journal">Mov Disord. </span>2014;<span class="ref-vol">29</span>:1201–4.</span> [<a href="/pubmed/24676999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24676999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.barreto.2015.s304">Barreto R, Lopes M, Roriz JM, Magalh&#x000e3;es M. Perry syndrome &#x02013; Characteristics of the first Portuguese family. <span><span class="ref-journal">Mov Disord. </span>2015;<span class="ref-vol">30</span>:S304–5.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.bhatia.1993.842">Bhatia KP, Daniel SE, Marsden CD. Familial parkinsonism with depression: a clinicopathological study. <span><span class="ref-journal">Ann Neurol. </span>1993;<span class="ref-vol">34</span>:842–7.</span> [<a href="/pubmed/8250534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8250534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.cady.2015.100">Cady J, Allred P, Bali T, Pestronk A, Goate A, Miller TM, Mitra RD, Ravits J, Harms MB, Baloh RH. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. <span><span class="ref-journal">Ann Neurol. </span>2015;<span class="ref-vol">77</span>:100–13.</span> [<a href="/pmc/articles/PMC4293318/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4293318</span></a>] [<a href="/pubmed/25382069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25382069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.caroppo.2014.208">Caroppo P, Le Ber I, Clot F, Rivaud-P&#x000e9;choux S, Camuzat A, De Septenville A, Boutoleau-Bretonni&#x000e8;re C, Mourlon V, Sauv&#x000e9;e M, Lebouvier T, Bonnet AM, Levy R, Vercelletto M, Brice A, et al.  DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes. <span><span class="ref-journal">JAMA Neurol. </span>2014;<span class="ref-vol">71</span>:208–15.</span> [<a href="/pmc/articles/PMC4169198/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4169198</span></a>] [<a href="/pubmed/24343258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24343258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.chung.2014.388">Chung EJ, Hwang JH, Lee MJ, Hong JH, Ji KH, Yoo WK, Kim SJ, Song HK, Lee CS, Lee MS, Kim YJ. Expansion of the clinicopathological and mutational spectrum of Perry syndrome. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2014;<span class="ref-vol">20</span>:388–93.</span> [<a href="/pubmed/24484619" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24484619</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.elibol.2002">Elibol B, Kobayashi T, Atac FB, Hattori N, Sahin G, Gurer G. Familial parkinsonism with apathy, depression and central hypoventilation (Perry's syndrome). In: Mizuno Y, ed. <em>Mapping the Progress of Alzheimer's and Parkinson's Disease.</em> Boston, MA: Kluwer Academic/Plenum Publishers; 2002:285-90.</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.farrer.2009.163">Farrer MJ, Hulihan MM, Kachergus JM, D&#x000e4;chsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilari&#x000f1;o-G&#x000fc;ell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK. DCTN1 mutations in Perry syndrome. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:163–5.</span> [<a href="/pmc/articles/PMC2813485/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2813485</span></a>] [<a href="/pubmed/19136952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19136952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.felicio.2014.1197">Felicio AC, Dinelle K, Agarwal PA, McKenzie J, Heffernan N, Road JD, Appel-Cresswell S, Wszolek ZK, Farrer MJ, Schulzer M, Sossi V, Stoessl AJ. In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers. <span><span class="ref-journal">Mov Disord. </span>2014;<span class="ref-vol">29</span>:1197–201.</span> [<a href="/pmc/articles/PMC4139463/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4139463</span></a>] [<a href="/pubmed/24797316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24797316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.gustavsson.2016.56">Gustavsson EK, Trinh J, Guella I, Szu-Tu C, Khinda J, Lin CH, Wu RM, Stoessl J, Appel-Cresswell S, McKeown M, Rajput A, Rajput AH, Petersen MS, Jeon BS, Aasly JO, Farrer MJ. DCTN1 p.K56R in progressive supranuclear palsy. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2016;<span class="ref-vol">28</span>:56–61.</span> [<a href="/pubmed/27132499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27132499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.lechevalier.2005.481">Lechevalier B, Chapon F, Defer G, Rivrain Y, Le Doze F, Schupp C, Viader F. Perry and Purdy's syndrome (familial and fatal parkinsonism with hypoventilation and athymhormia). <span><span class="ref-journal">Bull Acad Natl Med. </span>2005;<span class="ref-vol">189</span>:481–90.</span> [<a href="/pubmed/16149212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16149212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.lechevalier.1992.39">Lechevalier B, Schupp C, Fallet-Bianco C, Viader F, Eustache F, Chapon F, Morin P. Familial parkinsonian syndrome with athymhormia and hypoventilation. <span><span class="ref-journal">Rev Neurol. </span>1992;<span class="ref-vol">148</span>:39–46.</span> [<a href="/pubmed/1604112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1604112</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.levy.2006.733">Levy JR, Sumner CJ, Caviston JP, Tokito MK, Ranganathan S, Ligon LA, Wallace KE, LaMonte BH, Harmison GG, Puls I, Fischbeck KH, Holzbaur EL. A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. <span><span class="ref-journal">J Cell Biol. </span>2006;<span class="ref-vol">172</span>:733–45.</span> [<a href="/pmc/articles/PMC2063705/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2063705</span></a>] [<a href="/pubmed/16505168" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16505168</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.liu.2014.2881.e11">Liu ZJ, Li HF, Tan GH, Tao QQ, Ni W, Cheng XW, Xiong ZQ, Wu ZY. Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system. <span><span class="ref-journal">Neurobiol Aging. </span>2014;<span class="ref-vol">35</span>:2881.e11–5.</span> [<a href="/pubmed/25109764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25109764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.lloyd.2012.344">Lloyd TE, Machamer J, O'Hara K, Kim JH, Collins SE, Wong MY, Sahin B, Imlach W, Yang Y, Levitan ES, McCabe BD, Kolodkin AL. The p150(Glued) CAP-Gly domain regulates initiation of retrograde transport at synaptic termini. <span><span class="ref-journal">Neuron. </span>2012;<span class="ref-vol">74</span>:344–60.</span> [<a href="/pmc/articles/PMC3353876/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3353876</span></a>] [<a href="/pubmed/22542187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22542187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.moughamian.2012.331">Moughamian AJ, Holzbaur EL. Dynactin is required for transport initiation from the distal axon. <span><span class="ref-journal">Neuron. </span>2012;<span class="ref-vol">74</span>:331–43.</span> [<a href="/pmc/articles/PMC3347924/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3347924</span></a>] [<a href="/pubmed/22542186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22542186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.m_nch.2004.724">M&#x000fc;nch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G, Hanemann CO, Stumm G, Ludolph AC. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">63</span>:724–6.</span> [<a href="/pubmed/15326253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15326253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.m_nch.2005.777">M&#x000fc;nch C, Rosenbohm A, Sperfeld AD, Uttner I, Reske S, Krause BJ, Sedlmeier R, Meyer T, Hanemann CO, Stumm G, Ludolph AC. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">58</span>:777–80.</span> [<a href="/pubmed/16240349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16240349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.nam.2016.382">Nam SH, Hong YB, Hyun YS. Nam da E, Kwak G, Hwang SH, Choi BO, Chung KW. Identification of Genetic Causes of Inherited Peripheral Neuropathies by Targeted Gene Panel Sequencing. <span><span class="ref-journal">Mol Cells. </span>2016;<span class="ref-vol">39</span>:382–8.</span> [<a href="/pmc/articles/PMC4870185/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4870185</span></a>] [<a href="/pubmed/27025386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27025386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.newsway.2010.767">Newsway V, Fish M, Rohrer JD, Majounie E, Williams N, Hack M, Warren JD, Morris HR. Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:767–70.</span> [<a href="/pmc/articles/PMC4610057/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4610057</span></a>] [<a href="/pubmed/20437543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20437543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.ohshima.2010.612">Ohshima S, Tsuboi Y, Yamamoto A, Kawakami M, Farrer MJ, Kira J, Shii H. Autonomic failures in Perry syndrome with DCTN1 mutation. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2010;<span class="ref-vol">16</span>:612–4.</span> [<a href="/pubmed/20702129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20702129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.omoto.2012.762">Omoto M, Suzuki S, Ikeuchi T, Ishihara T, Kobayashi T, Tsuboi Y, Ogasawara J, Koga M, Kawai M, Iwaki T, Kanda T. Autosomal dominant tauopathy with parkinsonism and central hypoventilation. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:762–4.</span> [<a href="/pubmed/22357714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22357714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.perry.1975.108">Perry TL, Bratty PJ, Hansen S, Kennedy J, Urquhart N, Dolman CL. Hereditary mental depression and Parkinsonism with taurine deficiency. <span><span class="ref-journal">Arch Neurol. </span>1975;<span class="ref-vol">32</span>:108–13.</span> [<a href="/pubmed/1122173" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1122173</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.perry.1990.1882">Perry TL, Wright JM, Berry K, Hansen S, Perry TL Jr. Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases. <span><span class="ref-journal">Neurology. </span>1990;<span class="ref-vol">40</span>:1882–7.</span> [<a href="/pubmed/2247238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2247238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.pretelt.2014.620">Pretelt F, Casta&#x000f1;eda Cardona C, Tacik P, Ross OA, Wszolek ZK. Latin America's first case of Perry syndrome and a new treatment option for respiratory insufficiency. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:620–1.</span> [<a href="/pmc/articles/PMC3977388/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3977388</span></a>] [<a href="/pubmed/24500497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24500497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.puls.2003.455">Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH Jr, Ludlow CL, Fischbeck KH. Mutant dynactin in motor neuron disease. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:455–6.</span> [<a href="/pubmed/12627231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12627231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.puls.2005.687">Puls I, Oh SJ, Sumner CJ, Wallace KE, Floeter MK, Mann EA, Kennedy WR, Wendelschafer-Crabb G, Vortmeyer A, Powers R, Finnegan K, Holzbaur EL, Fischbeck KH, Ludlow CL. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">57</span>:687–94.</span> [<a href="/pmc/articles/PMC1351270/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1351270</span></a>] [<a href="/pubmed/15852399" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15852399</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.purdy.1979.523">Purdy A, Hahn A, Barnett HJ, Bratty P, Ahmad D, Lloyd KG, McGeer EG, Perry TL. Familial fatal Parkinsonism with alveolar hypoventilation and mental depression. <span><span class="ref-journal">Ann Neurol. </span>1979;<span class="ref-vol">6</span>:523–31.</span> [<a href="/pubmed/43704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 43704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.roy.1988.637">Roy EP 3rd, Riggs JE, Martin JD, Ringel RA, Gutmann L. Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management. <span><span class="ref-journal">Neurology. </span>1988;<span class="ref-vol">38</span>:637–9.</span> [<a href="/pubmed/3352925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3352925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.saka.2010.68">Saka E, Topcuoglu MA, Demir AU, Elibol B. Transcranial sonography in Perry syndrome. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2010;<span class="ref-vol">16</span>:68–70.</span> [<a href="/pubmed/19505837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19505837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.stockmann.2013.785">Stockmann M, Meyer-Ohlendorf M, Achberger K, Putz S, Demestre M, Yin H, Hendrich C, Linta L, Heinrich J, Brunner C, Proepper C, Kuh GF, Baumann B, Langer T, Schwalenst&#x000f6;cker B, Braunstein KE, von Arnim C, Schneuwly S, Meyer T, Wong PC, Boeckers TM, Ludolph AC, Liebau S. The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes. <span><span class="ref-journal">J Neural Transm. </span>2013;<span class="ref-vol">120</span>:785–98.</span> [<a href="/pubmed/23143281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23143281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.tacik.2014.884">Tacik P, Fiesel FC, Fujioka S, Ross OA, Pretelt F, Casta&#x000f1;eda Cardona C, Kidd A, Hlavac M, Raizis A, Okun MS, Traynor S, Strongosky AJ, Springer W, Wszolek ZK. Three families with Perry syndrome from distinct parts of the world. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2014;<span class="ref-vol">20</span>:884–8.</span> [<a href="/pmc/articles/PMC4125456/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4125456</span></a>] [<a href="/pubmed/24881494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24881494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.takahashi.2008.1326">Takahashi Y, Seki N, Ishiura H, Mitsui J, Matsukawa T, Kishino A, Onodera O, Aoki M, Shimozawa N, Murayama S, Itoyama Y, Suzuki Y, Sobue G, Nishizawa M, Goto J, Tsuji S. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis. <span><span class="ref-journal">Arch Neurol. </span>2008;<span class="ref-vol">65</span>:1326–32.</span> [<a href="/pubmed/18852346" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18852346</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.tsuboi.2008.263">Tsuboi Y, Dickson DW, Nabeshima K, Schmeichel AM, Wszolek ZK, Yamada T, Benarroch EE. Neurodegeneration involving putative respiratory neurons in Perry syndrome. <span><span class="ref-journal">Acta Neuropathol. </span>2008;<span class="ref-vol">115</span>:263–8.</span> [<a href="/pubmed/17576579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17576579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.tsuboi.2002.1025">Tsuboi Y, Wszolek ZK, Kusuhara T, Doh-ura K, Yamada T. Japanese family with parkinsonism, depression, weight loss, and central hypoventilation. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">58</span>:1025–30.</span> [<a href="/pubmed/11940687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11940687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.vilari_og_ell.2009.2024">Vilari&#x000f1;o-G&#x000fc;ell C, Wider C, Soto-Ortolaza AI, Cobb SA, Kachergus JM, Keeling BH, Dachsel JC, Hulihan MM, Dickson DW, Wszolek ZK, Uitti RJ, Graff-Radford NR, Boeve BF, Josephs KA, Miller B, Boylan KB, Gwinn K, Adler CH, Aasly JO, Hentati F, Dest&#x000e9;e A, Krygowska-Wajs A, Chartier-Harlin MC, Ross OA, Rademakers R, Farrer MJ. Characterization of DCTN1 genetic variability in neurodegeneration. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:2024–8.</span> [<a href="/pmc/articles/PMC2692178/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2692178</span></a>] [<a href="/pubmed/19506225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19506225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.wider.2010.149">Wider C, Dachsel JC, Farrer MJ, Dickson DW, Tsuboi Y, Wszolek ZK. Elucidating the genetics and pathology of Perry syndrome. <span><span class="ref-journal">J Neurol Sci. </span>2010;<span class="ref-vol">289</span>:149–54.</span> [<a href="/pmc/articles/PMC2813334/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2813334</span></a>] [<a href="/pubmed/19732908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19732908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.wider.2009.281">Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK. Pallidonigral TDP-43 pathology in Perry syndrome. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2009;<span class="ref-vol">15</span>:281–6.</span> [<a href="/pmc/articles/PMC2693935/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2693935</span></a>] [<a href="/pubmed/18723384" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18723384</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="perry.REF.wider.2008.1">Wider C, Wszolek ZK. Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature review. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2008;<span class="ref-vol">14</span>:1–7.</span> [<a href="/pubmed/17870652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17870652</span></a>]</div></li></ul></div></div><div id="perry.Chapter_Notes"><h2 id="_perry_Chapter_Notes_">Chapter Notes</h2><div id="perry.Acknowledgments"><h3>Acknowledgments</h3><p>Dr Wszolek is supported by NIH/NINDS P50NS072187, NIH/NIA (primary) and NIH/NINDS (secondary) 1U01AG045390-01A1, Mayo Center for Regenerative Medicine, Mayo Clinic Neuroscience Focused Research Team (Cecilia and Dan Carmichael Family Foundation, and the James C and Sarah K Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida), and The Sol Goldman Charitable Trust.</p><p>Dr Konno is supported by the JSPS Postdoctoral Fellowship for Research Abroad, and the gift from Carl Edward Bolch, Jr and Susan Bass Bolch.</p></div><div id="perry.Author_History"><h3>Author History</h3><p>Takuya Konno, MD (2016-present)<br />Christian Wider, MD; Centre Hospitalier Universitaire Vaudois, Lausanne (2010-2016)<br />Zbigneiw Wszolek, MD (2010-present)</p></div><div id="perry.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 September 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 May 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 September 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>3 May 2010 (cw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK47027</span><span class="label">PMID: <a href="/pubmed/20945553" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20945553</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/perrault/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/peters-plus/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK47027&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK47027/?report=reader">PubReader</a></li><li><a href="/books/NBK47027/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK47027" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK47027" style="display:none" title="Cite this Page"><div class="bk_tt">Wszolek Z, Konno T. Perry Syndrome. 2010 Sep 30 [Updated 2016 Sep 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK47027/pdf/Bookshelf_NBK47027.pdf">PDF version of this page</a> (188K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#perry.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#perry.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#perry.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#perry.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#perry.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#perry.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#perry.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#perry.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#perry.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#perry.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#perry.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1639[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DCTN1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK47027+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2334644" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2334644" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2334644" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2334644" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301600" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Central Hypoventilation Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Central Hypoventilation Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Weese-Mayer DE, Marazita ML, Rand CM, Berry-Kravis EM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24881494" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Three families with Perry syndrome from distinct parts of the world.</a><span class="source">[Parkinsonism Relat Disord. 2014]</span><div class="brieflinkpop offscreen_noflow">Three families with Perry syndrome from distinct parts of the world.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tacik P, Fiesel FC, Fujioka S, Ross OA, Pretelt F, Castañeda Cardona C, Kidd A, Hlavac M, Raizis A, Okun MS, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Parkinsonism Relat Disord. 2014 Aug; 20(8):884-8. Epub 2014 May 13.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28796472" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">VPS35</i>-Related Parkinson Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">VPS35</i>-Related Parkinson Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Deutschländer A, Ross OA, Wszolek ZK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301312" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Loeys BL, Dietz HC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20945553" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20945553" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041362dd21425a25c51bc8">Perry Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Perry Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:56:50-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B4622E03F98E100000000099E037A&amp;ncbi_session=CE8B4622E0413621_2462SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK47027%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK47027&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK47027/&amp;ncbi_pagename=Perry Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B4622E0413621_2462SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>